ScarX Therapeutics

ScarX Therapeutics Overview

Founded 2012
Founded
Status Out of Business
Employees 3
Employees
Latest Deal Type Out of Business

ScarX Therapeutics General Information

Description

Developer of innovative therapeutics intended to address excessive dermal scarring. The company's therapeutics are used to produce a small molecule therapeutic drug with anti-fibrotic activity that reduce dermal scarring during wound healing and also development of a novel therapeutic products, enabling patients to have better post-surgical outcomes following cosmetic and reconstructive plastic surgeries.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Personal Products
Drug Discovery
Primary Office
  • 661 University Avenue
  • Suite 465
  • Toronto, Ontario M5G 1M1
  • Canada
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ScarX Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 11-Dec-2019 00.00 Completed Out of Business
3. Early Stage VC (Series A) 16-Feb-2016 000 00.00 Completed Clinical Trials - Phase 1
2. Grant 24-Jan-2013 $1M $1.7M Completed Pre-Clinical Trials
1. Early Stage VC 25-Sep-2012 $1.7M $1.7M Completed Pre-Clinical Trials

Ready to get started?

Request a free trial